These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 22307672
1. Cardiomyocyte overexpression of the α1A-adrenergic receptor in the rat phenocopies second but not first window preconditioning. Zhao X, Park J, Ho D, Gao S, Yan L, Ge H, Iismaa S, Lin L, Tian B, Vatner DE, Graham RM, Vatner SF. Am J Physiol Heart Circ Physiol; 2012 Apr 15; 302(8):H1614-24. PubMed ID: 22307672 [Abstract] [Full Text] [Related]
2. Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling. Zhao X, Balaji P, Pachon R, Beniamen DM, Vatner DE, Graham RM, Vatner SF. Arterioscler Thromb Vasc Biol; 2015 Nov 15; 35(11):2451-9. PubMed ID: 26338300 [Abstract] [Full Text] [Related]
3. Obligatory role of cardiac nerves and alpha1-adrenergic receptors for the second window of ischemic preconditioning in conscious pigs. Kudej RK, Shen YT, Peppas AP, Huang CH, Chen W, Yan L, Vatner DE, Vatner SF. Circ Res; 2006 Nov 24; 99(11):1270-6. PubMed ID: 17068289 [Abstract] [Full Text] [Related]
4. Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes. Chaulet H, Lin F, Guo J, Owens WA, Michalicek J, Kesteven SH, Guan Z, Prall OW, Mearns BM, Feneley MP, Steinberg SF, Graham RM. J Mol Cell Cardiol; 2006 Apr 24; 40(4):540-52. PubMed ID: 16516910 [Abstract] [Full Text] [Related]
5. Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury. Oikawa M, Wu M, Lim S, Knight WE, Miller CL, Cai Y, Lu Y, Blaxall BC, Takeishi Y, Abe J, Yan C. J Mol Cell Cardiol; 2013 Nov 24; 64():11-9. PubMed ID: 23988739 [Abstract] [Full Text] [Related]
6. Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent. Lasley RD, Keith BJ, Kristo G, Yoshimura Y, Mentzer RM. Am J Physiol Heart Circ Physiol; 2005 Aug 24; 289(2):H785-91. PubMed ID: 15833799 [Abstract] [Full Text] [Related]
7. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. du Toit EF, Genade S, Carlini S, Moolman JA, Brunner F, Lochner A. Eur J Pharmacol; 2007 Feb 05; 556(1-3):115-20. PubMed ID: 17157294 [Abstract] [Full Text] [Related]
8. Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Lin F, Owens WA, Chen S, Stevens ME, Kesteven S, Arthur JF, Woodcock EA, Feneley MP, Graham RM. Circ Res; 2001 Aug 17; 89(4):343-50. PubMed ID: 11509451 [Abstract] [Full Text] [Related]
11. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase]. Shi EY, Jiang XJ, Bai H, Nakajima Y. Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):891-5. PubMed ID: 15329271 [Abstract] [Full Text] [Related]
12. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Imagawa J, Yellon DM, Baxter GF. Br J Pharmacol; 1999 Feb 02; 126(3):701-8. PubMed ID: 10188982 [Abstract] [Full Text] [Related]
13. Delayed or second window preconditioning induced by adenosine A1 receptor activation is independent of early generation of nitric oxide or late induction of inducible nitric oxide synthase. Dana A, Baxter GF, Yellon DM. J Cardiovasc Pharmacol; 2001 Aug 02; 38(2):278-87. PubMed ID: 11483878 [Abstract] [Full Text] [Related]